The efficacy of TLR9 ligands in combination with radiotherapy or as part of combination treatment with targeted therapy, monoclonal antibodies or cytokines is under investigation for the treatment of NHL [179]. Here, TLR9 is linked to non-Hodgkin lymphoma.